VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers
Keyword(s):
2018 ◽
Vol 24
(24)
◽
pp. 6523-6535
◽
2017 ◽
Vol 121
◽
pp. 202-212
◽
2016 ◽
Vol 34
(15_suppl)
◽
pp. e20600-e20600
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):